Exclusive

Publication

Byline

Fabtech Technologies IPO day 1 LIVE: GMP, price, subscription status, other details. Apply or not?

New Delhi, Sept. 29 -- Fabtech Technologies IPO day 1 LIVE: Bidding for the initial public offering (IPO) of Fabtech Technologies Limited is opening today and will remain open until 1 October 2025. Th... Read More


Fabtech Technologies IPO day 1: GMP, price, subscription status, other details. Apply or not?

New Delhi, Sept. 29 -- Fabtech Technologies IPO day 1 LIVE: Bidding for the initial public offering (IPO) of Fabtech Technologies Limited is opening today and will remain open until 1 October 2025. Th... Read More


Buy or sell: Vaishali Parekh recommends three stocks to buy today - 29 September 2025

Buy or sell stocks, Sept. 29 -- Following the escalation in trade worries after Trump's pharma tariff, the key benchmark indices of the Indian stock market ended lower for the seventh straight session... Read More


Trump's H-1B visa fee hike: TCS, Infosys to Wipro - is it opportune to buy IT stocks for long-term?

New Delhi, Sept. 27 -- After the H-1B visa fee hike to $1,00,000, the IT stocks of the Indian stock market have been under sell-off heat for the last few sessions. IT majors - Tata Consultancy Service... Read More


Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday - 29 September 2025

Buy or sell stocks, Sept. 27 -- Following the escalation in trade worries after Trump's 100% pharma tariff, the key benchmark indices of the Indian stock market ended lower for the seventh straight se... Read More


BSE share price tanks 30% from record high. Is the bottom around or more pain ahead?

BSE share price, Sept. 27 -- After climbing to a new peak of Rs.3,030 per share on the NSE in June 2025, BSE shares have remained under the bears' grip. BSE share price ended at Rs.2,047.90 per share ... Read More


H-1B visa fee hike to Trump's tariffs: Top reasons for FIIs' outflow in the Indian stock market

Indian stock market, Sept. 27 -- Following the escalation in trade worries after Trump's 100% pharma tariff, the key benchmark indices of the Indian stock market ended lower for the seventh straight s... Read More


Gold-equity ratio: Is it the right time to rejig exposure in bonds, Nifty 50 and Sensex-listed stocks?

Gold-equity ratio, Sept. 27 -- Gold prices continued their golden run for the sixth week and climbed to a new peak of Rs.1,14,179 per 10 gm on the Multi Commodity Exchange (MCX). MCX gold rate finishe... Read More


Trump's pharma tariffs: Sun Pharma, Cipla to Dr Reddy's - why experts see a sharp rebound on Monday? EXPLAINED

New Delhi, Sept. 27 -- In a dramatic development, the US President Donald Trump announced 100% conditional tariffs on the pharma imports from 1st October 2025. The US President made this announcement ... Read More


SBI, PNB, BPCL to BEL: Experts recommend these 10 PSU stocks to buy despite Trump's tariffs, H-1B visa fee hike row

New Delhi, Sept. 26 -- Trump tariffs on India, H-1B Visa fee hike: In the wake of 100% Trump's tariffs on pharma imports and the H-1B visa fee hike, market experts are suggesting that domestic equity ... Read More